HOAG ORTHOPEDIC INSTITUTE
1. Target Overview & Investment Thesis
HOAG ORTHOPEDIC INSTITUTE is a 70-bed suburban community hospital in nan, CA with $150.8M in net patient revenue and a 31.1% operating margin. The hospital serves a payer mix of 45.9% Medicare, 0.0% Medicaid, and 54.0% commercial.
Thesis: Turnaround. Our ML models identify $11.1M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 31.1% to 38.5% (+736bps).
| Net Revenue HCRIS | $150.8M |
| Current EBITDA COMPUTED | $46.9M |
| Operating Margin COMPUTED | 31.1% |
| Occupancy HCRIS | 17.7% |
| Revenue / Bed COMPUTED | $2.2M |
| Net-to-Gross HCRIS | 27.3% |
| Distress Probability ML | 53.6% |
2. Market Context & Competitive Position
CA has 414 Medicare-certified hospitals with a median operating margin of -4.9%. The target's margin of 31.1% places it above the state median. Among 139 size-comparable peers (35-140 beds), the median margin is -4.9%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (35-140), prioritizing same-state peers. 139 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| HOAG ORTHOPEDIC INSTITUTE (Target) | CA | 70 | $150.8M | 31.1% |
| CONTRA COSTA REGIONAL MEDICAL | CA | 124 | $595.0M | -29.2% |
| RANCHO LOS AMIGOS NATL.REHAB.C | CA | 83 | $512.6M | 41.9% |
| USC NORRIS CANCER HOSPITAL | CA | 60 | $468.7M | 19.1% |
| EDEN MEDICAL CENTER | CA | 126 | $389.8M | 2.7% |
| KFH - REDWOOD CITY | CA | 140 | $379.7M | -4.5% |
| SUTTER SANTA ROSA REGIONAL HOS | CA | 124 | $374.4M | -0.2% |
| DESERT VALLEY HOSPITAL INC. | CA | 138 | $350.1M | 5.4% |
| ST. JOSEPH HOSPITAL - EUREKA | CA | 132 | $331.9M | -16.9% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $11.1M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $3.2M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $3.0M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $3.0M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $1.8M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $97K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $46.9M |
| + RCM Uplift | +$11.1M |
| Pro Forma EBITDA | $58.0M |
| Current Margin | 31.1% |
| Pro Forma Margin | 38.5% |
| WC Released (1x) | $5.8M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $72.2M | $420.6M | 5.83x | 42.2% |
| Base (11x exit) | 10.0x | 11.0x | $72.2M | $486.1M | 6.73x | 46.4% |
| Bull Case | 9.0x | 11.0x | $65.0M | $546.2M | 8.41x | 53.1% |
| Bull (12x exit) | 9.0x | 12.0x | $65.0M | $615.0M | 9.46x | 56.8% |
| Bear Case | 11.0x | 10.0x | $79.4M | $341.6M | 4.30x | 33.9% |
| Bear (11x exit) | 11.0x | 11.0x | $79.4M | $401.6M | 5.06x | 38.3% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| Medium | Low occupancy | At 17.7%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case |
| High | Elevated distress probability | Model estimates 53.6% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 139 hospitals with 35-140 beds
- Same-state prioritization (n=140)
- Comp margins: P25=-21.0% / P50=-4.9% / P75=2.5%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.